CompaniesArrow Therapeutics

Arrow Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

122

By Phase

PHASE1: 3PHASE1/PHASE2: 1PHASE2: 1

By Status

COMPLETED: 4TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
Today
NCT00781976
Hover over trial bars to see details

Recent Trials

NCT01097408Lead Sponsor
Pharmacokinetics of AZD7295 Capsules
PHASE1Completed
12 participants
Started: Mar 31, 2010 · Completed: Aug 31, 2010
NCT00906256Lead Sponsor
Clinical Pharmacology Study of AZD7295 in Healthy Subjects
PHASE1Completed
16 participants
Started: Apr 30, 2009 · Completed: Jul 31, 2009
NCT00781976Lead Sponsor
Antiviral Activity of AZD7295 in HCV Carriers
PHASE1Completed
31 participants
Started: Nov 30, 2008 · Completed: Mar 31, 2010
NCT00522808Lead Sponsor
A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers
PHASE1/PHASE2Terminated
36 participants
Started: Aug 31, 2007 · Completed: May 31, 2008
NCT00232635Lead Sponsor
A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT
PHASE2Completed
27 participants
Started: Sep 30, 2005 · Completed: Jul 31, 2006